CACCIAPAGLIA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 520
EU - Europa 125
AS - Asia 18
OC - Oceania 2
Totale 665
Nazione #
US - Stati Uniti d'America 518
SE - Svezia 74
BE - Belgio 12
FR - Francia 12
CN - Cina 11
GB - Regno Unito 11
IT - Italia 9
DE - Germania 5
IN - India 4
AU - Australia 2
CA - Canada 2
AT - Austria 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
MN - Mongolia 1
Totale 665
Città #
Chandler 107
Nyköping 56
Fairfield 53
Ann Arbor 39
Ashburn 36
Seattle 28
Woodbridge 28
Houston 25
Wilmington 18
Cambridge 17
Brussels 12
Lawrence 11
Roxbury 10
Dearborn 8
Brooklyn 7
Paris 7
New York 6
Des Moines 5
Redwood City 5
Beijing 4
San Diego 4
Inglewood 3
London 3
Naples 3
Pune 3
San Mateo 3
Massa 2
Melbourne 2
Toronto 2
Washington 2
Ardabil 1
Augusta 1
Bari 1
Berlin 1
Boardman 1
Changsha 1
Esslingen am Neckar 1
Hefei 1
Hounslow 1
Jakarta 1
Jiaxing 1
Kilburn 1
Kunming 1
Leawood 1
Mumbai 1
Nagold 1
Prescot 1
Princeton 1
San Francisco 1
Shaoxing 1
Shenyang 1
Taranto 1
Ulan Bator 1
Vienna 1
Zagreb 1
Totale 534
Nome #
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 84
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 83
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 78
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 75
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 72
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 64
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 55
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 31
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 27
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 25
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 25
Complete Hydatidiform Mole Mimicking Sacroiliitis 13
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 11
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 7
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 7
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 7
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 6
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 6
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 5
Letters to the editors 5
Totale 686
Categoria #
all - tutte 4.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 0 37 38 26 28 8 10 2
2020/202186 3 13 4 8 6 9 1 12 2 12 10 6
2021/2022119 3 3 4 3 11 10 7 6 8 14 15 35
2022/2023251 23 40 17 25 18 36 8 35 29 4 11 5
2023/202481 4 24 8 11 9 18 1 6 0 0 0 0
Totale 686